Form 4: 10x Genomics CFO Sells Shares
Insider Transaction (Form 4)
Adam Taich, Chief Financial Officer of 10x Genomics, Inc., sold 46,388 shares of common stock on September 9, 2026.
Summary
- Open-market sale: disposed of 1,206 Class A Common Stock at $63.68 ($76,795) on September 9, 2026; holds 361,526 after (Direct).
- Open-market sale: disposed of 31,428 Class A Common Stock at $64.31 ($2,021,125) on September 9, 2026; holds 330,098 after (Direct).
- Open-market sale: disposed of 13,754 Class A Common Stock at $65.26 ($897,550) on September 9, 2026; holds 316,344 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,995,470 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Adam Taich — Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-09 | Open-market sale | Class A Common Stock | 1,206 | $64 | $76.8K | 361,526 |
| 2026-09-09 | Open-market sale | Class A Common Stock | 31,428 | $64 | $2.0M | 330,098 |
| 2026-09-09 | Open-market sale | Class A Common Stock | 13,754 | $65 | $897.6K | 316,344 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-09 | Open-market sale (1,206 shares) |
| 2026-09-09 | Open-market sale (31,428 shares) |
| 2026-09-09 | Open-market sale (13,754 shares) |
Keywords
insider transaction, Form 4, TXG, 10x Genomics, Inc., bearish, Adam Taich
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.